Basic Tumor Immunology

TFEB is a master regulator of tumor-associated macrophages in breast cancer
Yong Li, Johnie Hodge, Qing Liu, Junfeng Wang, Yuzhen Wang, Trent D Evans, Diego Altomare, Yongzhong Yao, E Angela Murphy, Babak Razani, Daping Fan

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000543; DOI: 10.1136/jitc-2020-000543
CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma
Rehana Hewavisenti, Angela Ferguson, Kevin Wang, Deanna Jones, Thomas Gebhardt, Jarem Edwards, Mei Zhang, Warwick Britton, Jean Yang, Angela Hong, Umaimainthan Palendira

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000452; DOI: 10.1136/jitc-2019-000452
Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103⁺ conventional dendritic cells
Yifan Zhou, Natalie Slone, Taylor T Chrisikos, Oleksandr Kyrysyuk, Rachel L Babcock, Yusra B Medik, Haiyan S Li, Eugenie S Kleinerman, Stephanie S Watowich

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000474; DOI: 10.1136/jitc-2019-000474
HDAC9 deficiency promotes tumor progression by decreasing the CD8⁺ dendritic cell infiltration of the tumor microenvironment
Yongling Ning, Jun Ding, Xiao Sun, Yewen Xie, Mingming Su, Chenglong Ma, Jie Pan, Jie Chen, Hua Jiang, Chunjian Qi

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000529; DOI: 10.1136/jitc-2020-000529
Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer
Fang Bai, Peng Zhang, Yipeng Fu, Hongliang Chen, Mingdi Zhang, Qianru Huang, Dan Li, Bin Li, Kejin Wu

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000169; DOI: 10.1136/jitc-2019-000169
Immune involvement of the contralateral hemisphere in a glioblastoma mouse model
Matheus H W Crommentuijn, Sjoerd T T Schetters, Sophie A Dusoswa, Laura J W Kruijssen, Juan J Garcia-Vallejo, Yvette van Kooyk

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000323; DOI: 10.1136/jitc-2019-000323
FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion
Robert J Oldham, C Ian Mockridge, Sonya James, Patrick J Duriez, H T Claude Chan, Kerry L Cox, Vicentiu A Pitic, Martin J Glennie, Mark S Cragg

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000619; DOI: 10.1136/jitc-2020-000619
Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms
Alexander J Neuwelt, Abigail K Kimball, Amber M Johnson, Benjamin W Arnold, Bonnie L Bullock, Rachael E Kaspar, Emily K Kleczko, Jeff W Kwak, Meng-Han Wu, Lynn E Heasley, Robert C Doebele, Howard Y Li, Raphael A Nemenoff, Eric T Clambey

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000441; DOI: 10.1136/jitc-2019-000441
Fetal exposure to oncoantigen elicited antigen-specific adaptive immunity against tumorigenesis
Jeng-Chang Chen, Liang-Shiou Ou, Ming-Ling Kuo, Li-Yun Tseng, Hsueh-Ling Chang

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000137; DOI: 10.1136/jitc-2019-000137
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy
Jared E Lopes, Jan L Fisher, Heather L Flick, Chunhua Wang, Lei Sun, Marc S Ernstoff, Juan C Alvarez, Heather C Losey

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000673; DOI: 10.1136/jitc-2020-000673

Main menu

Basic Tumor Immunology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Basic Tumor Immunology

Pages